Introduction
The catechol-O-methyltransferase (COMT) gene is one of the most investigated candidate genes for schizophrenia because of its role in the degradation of dopamine (DA). This gene contains a common functional variant, the Val 158 Met polymorphism, which impairs the thermostability of the mature protein, altering DA levels in several brain regions and specifically in the prefrontal cortex. 1, 2 To date, several metaanalyses have investigated the association between the COMT Val 158 Met polymorphism and schizophrenia: although the evidence is controversial, the most recent metaanalysis points to a weak association between the COMT Val 158 Met polymorphism and schizophrenia (from the Schizo phrenia Research Forum, www.szgene .org /meta .asp ?geneID =420). [3] [4] [5] [6] Interestingly, the dopaminergic system is also involved in some of the neuropsychological impairments frequently described in patients with schizophrenia. 7 These impairments are thought to represent the functional correlate of abnormalities in the structure of the brain areas involved in these functions (for a review, see Antonova and colleagues 8 ).
Interestingly, there is evidence that the COMT Val allele itself may be associated with abnormalities in these areas in patients with schizophrenia. [9] [10] [11] The COMT Val 158 Met polymorphism may therefore contribute to the risk for schizophrenia by influencing specific neuropsychological impairments and brain structural abnormalities, which have been proposed as endophenotypes for this disorder. 12, 13 Endophenotypes are heritable traits that possibly represent a causal link between genes and observable phenotypes.
14 They have the advantage of being measurable using strategies that involve quantitative units of analysis, and of being amenable to assessment in the laboratory. 15 Furthermore, the association between a specific endophenotype and certain genetic variants could be stronger than that with the illness itself.
14 According to Gottesman and Gould, 14 an endophenotype should • be associated with the illness in the population of interest, • be heritable, • be primarily state independent, • cosegregate with the illness within families, and • be present in nonaffected family members more frequently than in the general population. Endophenotypes in genetic psychiatry may increase our understanding of the molecular mechanisms underlying disease risk and its manifestations. Thus, investigating the link between neuropsychological impairments and brain structural abnormalities associated with COMT Val 158 Met in schizophrenia may provide a better understanding of the pathophysiology of this disorder.
Although many studies have investigated the relationship between the COMT Val 158 Met polymorphism and neuropsychological impairments or brain structural alterations in patients with schizophrenia, in their relatives and in healthy individuals, to our knowledge, no systematic review has critically appraised this evidence and explored the potential relationship between this polymorphism and neuropsychological impairments or the brain structural alterations. We sought to fill this gap with the present systematic review.
Methods
A flow chart of the methodology is presented in Figure 1 . In step 1, we searched the PubMed and MEDLINE databases, from the date of the first available article to July 2012, to systematically identify the neuropsychological tasks and brain structural variations reported, as related to the COMT Val 158 Met polymorphism, across disorders in the psychosis spectrum. To investigate the association between COMT and neuropsychological tasks, we used the terms "catechol-Omethyltransferase" or "COMT" AND "cognitive" or "cognition" or "neuropsychological" or "neuropsychology" or "attention" or "memory" or "executive function" AND "schizophrenia" or "psychosis" or "schizoaffective" or "schizophreniform" or "healthy." To investigate the association between COMT and brain structure we used the terms "catechol-O-methyltransferase" or "COMT", AND "MRI" or "magnetic resonance imaging" or "imaging" or "voxel" or "brain structures" AND "schizophrenia" or "psychosis" or "schizoaffective" or "schizophreniform" or "healthy." We also manually searched the reference lists of the articles identified in our search. Unpublished studies, conference abstracts and poster presentations were not included. One of us (E.I.) selected the articles, which 2 of us (P.D. and S.T.) then checked against our inclusion criteria.
We included studies that fulfilled the following criteria. First, studies must have evaluated the association between the COMT Val 158 Met polymorphism and neuropsychological tasks in patients with diagnosed schizo phrenia-spectrum disorders (i.e., schizophrenia, schizo phreniform disorder, schizoaffective disorder) and/or in healthy controls and/or in relatives of patients with psychosis. We included only studies conducted using a standardized cognitive measure in adult participants. Behavioural data from functional magnetic resonance imaging (fMRI) studies were also included when reported. Second, studies must have evaluated the association between the COMT Val 158 Met polymorphism and brain volumes using structural MRI in patients with diagnosed schizophrenia-spectrum disorders and/or in healthy controls and/or in relatives of patients with psychosis.
From the studies reviewed, we selected neuropsychological tasks and brain structures strongly associated with the COMT Val 158 Met polymorphism according to the following criteria. First, at least 3 studies must have evaluated the association between COMT and those neuropsychological tasks or brain structures in either patients or healthy controls. Second, at least 50% of these studies must have reported an association in patients.
In step 2, we considered each neuropsychological task and brain structure identified in step 1 to establish whether they satisfied the criteria for endophenotypes.
In step 3, we systematically searched the PubMed and MEDLINE databases, from the date of the first available article to July 2012, to verify whether the neuropsychological and the brain structural endophenotypes identified in step 2 were associated with each other. We used the name of each neuropsychological task as a search term combined with the terms "MRI" or "magnetic resonance imaging" or "imaging" or "voxel" or "brain structures" AND "schizophrenia" or "psychosis" or "schizoaffective" or "schizophreniform" or "healthy." In addition, we manually searched the reference lists of the articles identified in our search. Unpublished studies, conference abstracts and poster presentations were not included.
Results
Step 1a: association between the COMT Val 158 
Met polymorphism and neuropsychological tests
We identified 53 studies ( Table 1 ) that explored the association between the COMT Val 158 Met polymorphism and various neuropsychological tests. We present the neuropsychological tests that satisfied our first criterion (i.e., at least 3 studies evaluated the association between the COMT Val 158 Met polymorphism and those neuropsychological tests in either patients or healthy controls).
N-back task
The n-back task is conceptualized as a measure of working memory and includes executive functions, such as encoding, updating, sequence maintenance, comparing and deciding. 44 Eleven studies satisfied our inclusion criteria and together suggest that while the COMT Val 158 Met polymorphism seems to be associated with performance on the n-back task in patients with schizophrenia and schizoaffective disorder and in their siblings, this association is not present in healthy individuals. Three studies resported a significant or trendlevel association between the Val/Val genotype and a worse performance (accuracy and reaction time) on the n-back task in patients with schizophrenia, schizophreniform disorder and schizoaffective disorder 26, 40, 64 and in their relatives, 40, 64 whereas 1 study found no association. 27 Interestingly, the 3 studies that detected a significant association used a version of the n-back task that requires a higher cognitive load, suggesting that the association between the COMT Val 158 Met polymorphism and performance on the n-back task in patients with schizophrenia-spectrum disorders may become apparent when a more challenging performance is required (for details about the different versions of the tasks used, see Appendix 1, Table S1 , available at cma.ca/jpn). In healthy individuals, 3 studies found a significant association between the COMT Val 158 Met polymorphism and performance on the n-back task. 30, 40, 64 In 2 of these studies the Val/Val genotype was associated with worse performance, 40, 64 whereas in the third one participants with the Val/Met genotype performed worse than those with the Met/Met or Val/Val genotype. 30 Eight studies did not find a COMT Val 158 Met genotype effect on n-back task performance in healthy individuals. 18, 21, 26, 27, 41, 44, 47, 58 
Continuous Performance Test (CPT)
The CPT is conceptualized as a behavioural assessment of attentional modulation; it can detect deficits in vigilance, selective attention and sustained attention. 68 Ten studies satisfied our inclusion criteria, reporting inconsistent findings on the association between the CPT and the COMT Val 158 Met polymorphism in both patients with schizophrenia and healthy individuals. In patients, 3 studies found a significant association between the Val/Val genotype and a poorer performance in terms of number of errors 57, 69 and a better performance in terms of signal discrimination. 32 In contrast, 2 studies found no association either in patients with schizophrenia and schizoaffective disorder or in their relatives. 40, 64 In healthy individuals, the Val/Val and Val/Met genotypes have been associated with worse performance in terms of commission errors, 47 context processing 44 and reaction time variability in some studies, 55 whereas other studies reported no association. 23, 40, 42, 64 This inconsistency may be related to the use of different versions of the CPT across studies (for details about the different versions of the tasks used, see Appendix 1, Table S1 ). Interestingly, 1 study reported an interaction between the COMT Val 158 Met polymorphism and the DAT 40 bp variable number tandem repeat; participants homozygous for both the COMT Val allele and the DAT 10 allele exhibited worse performance in terms of commission errors. 47 This result suggests that the COMT Val 158 Met polymorphism may affect CPT performance by interacting with other genes, which may also explain inconsistencies in previous findings.
Wisconsin Card Sorting Test (WCST)
The WCST is regarded as a neuropsychological marker of the efficiency of executive functions. 70 While the COMT gene appears to have no effect on WCST performance in patients with psychosis, it seems to have an effect in healthy individ uals. A meta-analysis has been conducted to assess the effect of the COMT Val 158 Met polymorphism on WCST perseverative errors in patients with schizophrenia-spectrum disorders and in healthy controls; 48 this included 11 studies that met our inclusion criteria. 1, 49, 50, [56] [57] [58] 60, 63, [65] [66] [67] The meta-analysis revealed a small but significant association between the COMT Val 158 Met polymorphism and executive function in healthy individuals, 
No association between COMT and any cognitive measures 42 or unaffected relatives. 40 Moreover, an interaction between the COMT Val 158 Met polymorphism and the MTHFR C677T mutation on WCST performance has been found in patients with schizophrenia, with COMT Val/Val carriers who had at least 1 copy of the MTHFR T allele making more perseverative errors. 37 
Trail Making Test (TMT) A and B
The TMT-A requires sequencing, psychomotor speed and visuoperceptual ability; part B also requires cognitive flexibility and working memory. 71, 72 Performance on the TMT-A has not been found to be associated with the COMT Val 158 Met polymorphism in pa tients with schizophrenia 45, 49, 56 or healthy individuals. 20, 28, 56 Worse performance on the TMT-B has been found to be associated with Val/Val and Val/Met genotypes in healthy individ uals in 1 study 20 but not in others, 28, 56 nor in those evaluating patients with schizophrenia. 45, 49, 56 Interestingly, an association between the COMT Val 158 Met polymorphism and worse TMT-B performance has been reported in healthy individuals carrying both the COMT Val allele and the ANKK1 (rs1800497) T allele.
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Verbal fluency
Verbal fluency is considered to be an executive function task and a semantic memory measure. 53 Both Val/Val and Val/Met carriers with schizophrenia have been reported to perform worse in 1 study, 33 but this association has not been confirmed by other studies involving patients with schizophrenia, 26 
Digit span
Composed by 2 parts, forward and backward, the digit span test is considered to be a short-term memory measure, with the digit span backward also involving working memory. 56 A worse performance on digit span has been found to be related to the Val/Val genotype in patients with schizophrenia and schizoaffective disorder in 1 study, 52 but not in another study involving patients with schizophrenia. 19 Of note, the sample size of the former study 52 was considerably larger than that in the latter study. 19 Only the digit span backward has not been found to be associated with the COMT Val 158 Met polymorphism in patients with schizophrenia. 74 According to our criteria, only the n-back task and the CPT can be considered strongly related to the COMT Val 158 Met polymorphism in patients with schizophrenia. In healthy controls, these associations seem to be weaker or absent. Interestingly, some fMRI studies that used an n-back paradigm detected a significant association between the COMT Val 158 Met polymorphism and the activation of the frontal cortex in patients with schizophrenia 26 and healthy controls 21,26,41,75 regardless of n-back task performance. Thus, fMRI may be a more sensitive approach to the evaluation of the neuronal circuitry affected by variation in the COMT gene and n-back task performance and when cognitive performance is not affected. The n-back task and the CPT assess working memory and attention modulation, respectively. Interestingly, although the evidence available is not yet sufficient to make them satisfy our criteria of performance in other working memory tasks (e.g., letter and number sequencing, Auditory Consonant Trigram Test) and in tasks of attentional modulation (e.g., Attention Network Test, Variable Attentional Control Task), these tasks seem to be associated with the COMT Val 158 Met polymorphism in patients with schizophrenia. On the other hand, verbal fluency and digit span backward have not been found to be associated with the COMT Val 158 Met polymorphism in patients with schizophrenia or in healthy controls. However, this result may reflect the lack of association between the COMT Val 158 Met polymorphism and semantic and short-term memory, respectively, which are both required for performing these tasks.
The WCST, which assesses executive function, has been related to the COMT Val 158 Met polymorphism in healthy controls but not in patients with psychosis. 48 It is plausible that other COMT polymorphisms or other genetic variants or nongenetic factors might influence the performance on this task in individuals with psychosis.
Step 1b: Association between the COMT Val 158 Met polymorphism and brain structure
We identified 13 studies (Table 2 ) exploring the association between brain structure (global or regional volumes of grey and white matter) and the COMT Val 158 Met polymorphism. We report the regions that satisfied the first criterion (i.e., at least 3 studies evaluated the association between the COMT Val 158 Met polymorphism and those brain areas in either patients or healthy controls).
Temporal regions
The most consistent finding has been that of an association with temporal areas. In patients with schizophrenia, a smaller volume of the hippocampus, 9 amygdala-uncus 9,11 and middle temporal gyrus 11 has been associated with the Val/Val and Val/Met genotypes. Interestingly, this association has not been found in studies that included patients with any psychosis, 79, 80, 83 indicating that the association may be specific to schizophrenia. In healthy individuals, smaller hippocampal, 9,78,81,82 amygdalar, 9 total and grey matter temporal lobe 82 volumes as well as reduced thickness of the right superior temporal sulcus 77 have been reported in Val/Val carriers. In contrast, other studies have failed to find a significant association between the COMT Val 158 Met polymorphism and temporal lobe volumes in healthy individuals or in unaffected relatives of patients with psychosis.
11,79,84
Frontal areas
The Val/Val genotype has been associated with smaller grey matter density in the anterior cingulate cortex in a popu lation at high risk for psychosis 10 and with smaller grey matter volume in the left anterior cingulate cortex in patients with chronic schizophrenia. 11 However, these findings have not been replicated by other studies. 9, 56, 83 Interestingly, carriers of both the COMT Val allele and the PRODH GT or TT genotypes for rs20086720 have been found to have larger white matter volume of the inferior frontal area. 80 This may suggest that the COMT Val 158 Met polymorphism affects frontal region morphology via an interaction with other genes, which may help explain the inconsistency found in the association between the COMT Val 158 Met polymorphism and frontal volumes. In healthy individuals, both the Val/Val and Val/Met genotypes have been associated with greater grey matter volume of the prefrontal, 81 and (albeit at trend level) dorsolateral prefrontal cortex 78 and with a reduced thickness of the right inferior prefrontal sulcus; 77 however, these findings have not been confirmed by other studies. 9, 11, 56, 76, 84 
Lateral ventricles
In patients with first-episode schizophrenia with nonaffective psychoses, a significant enlargement of lateral ventricles has been reported in both Met/Met and Val/Met carriers. 83 This finding has not been replicated in studies involving patients with any psychosis, 11, 79 in unaffected relatives 79 or in healthy individuals.
11,79,84
Thalamus A reduced volume of the left thalamus has been associated with the COMT Val allele in patients with chronic schizophrenia, 11 but not in healthy controls. 11, 84 Subsequent studies have not confirmed this association in patients. 80, 83 According to our criteria, only temporal and frontal volumes can be considered to correlate with the COMT Val 158 Met polymorphism in schizophrenia, with temporal volumes also associated with this genotype in healthy controls. Interestingly, the association between the COMT Val 158 Met polymorphism and temporal and frontal areas has also been explored in fMRI studies. The Val allele has been reported to be associated with a reduced activation of the medial temporal lobe during an episodic memory task in healthy controls, 54, 85 whereas in schizophrenia the Met allele has been reported to be associated with a reduced activation in this area. 86 Moreover, a recent meta-analysis 87 that evaluated 20 studies involving mostly healthy individuals showed a significant association between the Val allele and increased prefrontal acti vation. This finding has also been reported in patients with schizophrenia and in their relatives. 27, 67 Step 2a: Can the neuropsychological tasks identified (n-back and CPT) be considered endophenotypes?
N-back task
Association with the illness: Several studies suggest that patients with schizophrenia have worse n-back accuracy during high working memory load conditions and longer reaction time. 40, 64, 88 Heritability: The n-back heritability seems high, at 72.9% for accuracy and 56.4% for reaction time, as found in healthy twins. 89 State independence: Impairment in the n-back task has been reported in patients with schizophrenia at various illness stages, [90] [91] [92] before and after antipsychotic treatment 92 and independent of illness duration. 91 Cosegregation with illness within family: Cosegregation is suggested by evidence that this impairment is present in relatives of patients with schizophrenia, who perform better than probands. 40, 64, 88, 93 Moreover, a significant influence of familial loading on visuospatial working memory has been detected in patients with schizophrenia but not in patients with schizo affective disorder. 94 Presence in unaffected relatives: With the exception of 2 studies, 95, 96 n-back performance has been found to be impaired in unaffected relatives of patients with schizophrenia in comparison to healthy controls. 40, 64, 88, 93 Continuous Performance Test Association with the illness: Schizophrenia has been consistently associated with impairment in CPT discrimination accuracy and reaction time. 12, 40, 64, 97, 98 Heritability: The heritability for d' of the CPT, Identical Pairs version (CPT-IP), has been estimated at around 39% for verbal and 49% for spatial attention. 99 For the X-CPT, the heritability has been reported to vary between 48% and 62%. 100, 101 State independence: It has been reported that at-risk offspring in whom a schizophrenia-spectrum disorder later developed had attentional deficits as early as age 12 years, with the impairment persisting over the following 15 years. 102 Cosegregation with illness within family: CPT impairment may cosegregate with psychosis, as suggested by its presence among family members of patients with schizophrenia. 12 Moreover, there is evidence that nonpsychotic siblings from multiplex families exhibit worse performance on a degraded CPT version as well as less proficiency in processing the perceptual load when compared with those from simplex families. 103 Presence in unaffected relatives: Unaffected relatives of patients with schizophrenia show impairment in discrimination accuracy at the CPT-IP. 12 However, studies that used different versions of the CPT have not reported impairment in discrimination accuracy. 40, 64 Relatives of patients with schizophrenia have also been found to have an impairment in hit reaction time in comparison to healthy controls. 98 Both the n-back and the CPT can be considered useful endo phenotypes for schizophrenia.
Step 2b: Can the previously identified brain structures (temporal and frontal areas) be considered endophenotypes?
Temporal areas
Association with the illness: Meta-analyses suggest that a reduction of total and medial temporal (amygdala-uncushyppocampus) volumes is present in patients with schizophrenia, particularly in the hippocampus. [104] [105] [106] [107] [108] [109] [110] Heritability: A moderate heritability (40%-69%) for hippocampal volume has been reported in twin studies in healthy controls. 111 State independence: Hippocampus reductions seem to be state-independent and have been reported in patients at both first episode and chronic illness stages. 112 Cosegregation with illness within the family: Cosegregation is suggested by the presence of hippocampal volume reduction among relatives of patients with schizophrenia, 113 particularly in multiplex families. 114 Presence in unaffected relatives: Results from a metaanalysis indicate that amygdalar and hippocampal volume reductions are also present in relatives of patients with schizophrenia.
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Frontal areas
Association with the illness: Various meta-analyses have consistently reported volume reductions in medial prefrontal and anterior cingulate cortices [104] [105] [106] 115 in patients with schizophrenia.
Heritability: The heritability of total frontal lobe volumes seems to be high (90%-95%); changes in ventrolateral prefrontal cortex, anterior cingulate gyrus, superior frontal cortex and anterior cingulate volumes have also been found to be highly heritable. 111 Moreover, a twin study has reported an association between smaller prefrontal grey matter volume and increasing genetic proximity to a patient with schizophrenia (monozygotic co-twins > dizygotic co-twins > control twins).
Cosegregation with illness within family: Cosegregation of the smaller prefrontal cortex within schizophrenia families is suggested by evidence of smaller volumes in this region in family members, albeit to a lesser extent than in affected relatives. 120, 121 Moreover, there is evidence of a negative correlation between grey matter volume and increasing genetic risk for schizophrenia. 122 Presence in unaffected relatives: Relatives of patients with schizophrenia show grey matter volume reductions in the total frontal lobe, 120 prefrontal cortex 123 and anterior cingulate gyrus 110, 115, 121 in comparison to healthy individuals. However, this finding has not been replicated in other studies. 124, 125 Reduced grey matter volume in the medial temporal and prefrontal cortices can be considered a useful endophenotype for schizophrenia.
Step 3: Are the previously identified neuropsychological endophenotypes associated with these brain structural endophenotypes?
Six studies (Table 3) have examined the association between the n-back and CPT and the brain structural endophenotypes we identified in step 2 (grey matter volume of medial temporal and prefrontal cortices).
N-back task
Although the association between n-back task and prefrontal brain function has been frequently explored with fMRI in patients with schizophrenia 88, [126] [127] [128] [129] and in their relatives, 95 the association between this test and prefrontal (or temporal) volume in patients with schizophrenia has not been explored. In healthy controls, only 1 study has been conducted, reporting no association between n-back performance and hippocampal and amygdalar volume. 130 However, reduced prefrontal activation during the n-back task has been associated with a reduction in prefrontal volume in people at ultra-high risk for psychosis, suggesting that "these 2 fundamental pathophysiological features of the disorder are interrelated." 117 Moreover, 2 studies that adopted working memory tasks similar to the n-back task (the Wechsler Adult Intelligence Scale arithmetic subtest and digit span backward, respectively) reported a association between worse working memory performance and reduced frontal, prefrontal and temporal lobe volumes in patients with schizophrenia. 131, 132 Taken together, these data suggest that worse n-back performance is associated with reduced prefrontal and temporal lobe volumes. Interestingly, an impaired performance on the n-back task has also been described in individuals with focal prefrontal damage, 133 suggesting that this deficit may be shared by other disorders that primarily affect the prefrontal cortex.
Continuous Performance Test
A worse CPT performance has been associated with smaller prefrontal volume in patients with schizophrenia, 134 but not in studies that included patients with any psychosis 8, 135, 136 or healthy individuals. 8, [134] [135] [136] Studies in patients with schizophrenia, their unaffected co-twins and healthy controls have found no association between CPT performance and hippocampal volume. 8, [134] [135] [136] [137] These findings suggest that worse performance on the n-back task is associated with smaller prefrontal and medial temporal volumes and that worse CPT performance is associated with smaller prefrontal volume in patients with schizophrenia. Consistent with this evidence, a meta-analysis of fMRI studies reported that the dorsolateral prefrontal cortex and the anterior cingulate cortex were less activated during the n-back task in patients with schizophrenia. 128 On the other hand, prefrontal cortex activation has been found to be associated with the CPT in patients with schizophrenia [138] [139] [140] and in their relatives.
141
Discussion
To our knowledge, this is the first systematic review to comprehensively evaluate evidence on the link between the COMT Val 158 Met polymorphism and neuropsychological performance and brain structures in patients with schizophrenia, in their relatives and in healthy controls. We found that the n-back task and the CPT (a working memory task and an attentional modulation task, respectively) are the only 2 neuropsychological tasks strongly associated with the COMT Val 158 Met polymorphism in patients with schizophrenia. More specifically, among patients, the Val/Val carriers showed a worse performance in both the n-back task and the CPT, with a greater number of errors, but a better performance in signal discrimination. Interestingly, evidence from fMRI studies suggests that performance on these 2 tasks is positively correlated with lower prefrontal cortex activation in patients with schizophrenia. This suggests that the cognitive domains assessed by these tasks reflect "the operation of a common underlying cognitive control mechanism supported by the prefrontal cortex." 142 Moreover, this evidence is consistent with the tonic-phasic DA hypothesis, 143 which suggests that tonic DA may stabilize and maintain relevant information ("cognitive stability") principally via D 1 receptors, while phasic DA is important for updating and manipulating information ("cognitive flexibility"), principally via D 2 receptors. 144 In the COMT Val 158 Met polymorphism, while the Val allele increases phasic DA transmission and is expected to improve cognitive flexibility, the Met 158 allele increases tonic DA transmission, and is therefore expected to improve working memory and executive functions that require cognitive stability. 145 Furthermore, since some neuropsychological tests require both cognitive stability and cognitive flexibility, 145 the DA hypothesis may help explain the inconsistency in findings regarding the association between the COMT Val 158 Met polymorphism and neuropsychological performance.
With respect to brain structure, the evidence reviewed points to an association between smaller temporal areas (e.g., hippocampus, amygdala, middle temporal gyrus) and the Val/Val and Val/Met genotypes in patients with schizophrenia. Smaller frontal areas also seem to be associated with the Val/Val genotype in patients with schizophrenia and in people at high risk for psychosis. This is interesting since CPT performance is associated with prefrontal cortex volume in patients with schizophrenia. Although, to our knowledge, no study has been conducted to date using the n-back task and structural MRI, we speculate that this test may be associated with both prefrontal and medial temporal volumes in view of evidence of prefrontal activation during the task 88, 95, [126] [127] [128] [129] and of an association between worse working memory performance and smaller frontal, prefrontal and temporal lobe volumes. 131, 132 Moreover, both neuropsychological tasks (n-back task and CPT) and brain regional volumes (medial temporal and prefrontal cortex), which have been reported to be associated with the COMT Val 158 Met polymorphism, met most of the criteria for an endophenotype.
Taken together, these results suggest that the COMT Val 158 Met polymorphism may contribute to 2 neuropsychological and 2 brain structural endophenotypes that characterize schizophrenia, with the prefrontal cortex representing a common neural substrate underlying both n-back task and CPT performance. It is interesting to note that the association between the COMT Val 158 Met polymorphism and the endophenotypes detected (with the exception of the hippocampus) is more evident in patients with schizophrenia than in healthy controls. This suggests that this polymorphism alone is not sufficient to produce a variation at the neuropsychological and brain structural levels. The presence of these endo phenotypes (e.g., working memory impairment, prefrontal cortex grey matter volume reduction) seems to result from an interaction between the COMT Val 158 Met polymorphism and other genetic and nongenetic (e.g., environmental) factors (possibly present in excess in affected individuals), which together contribute to shape the neuropsychological and brain structural alterations that characterize schizophrenia. 47, 80, 146 We speculate that alterations in the fine-tuning of cortical DA may be responsible for worse neuropsychological performance and for brain volume reductions. More specifically, the COMT Val carriers may have reduced DA levels in the prefrontal cortex, leading to a decrease in D 1 receptor activation with subsequent impairment in cognitive tasks, such as working memory. 147 In fact, working memory seems to be related to the activity of both D 1 and D 2 receptors: the D 1 receptors would signal to prefrontal pyramidal neurons via N-methyl-D-aspartate postsynaptic receptors, maintaining and stabilizing task-relevant signals while reducing signal-tonoise ratio in the prefrontal cortex via GABAergic inhibitory effect on nonrelevant "noisy" signals. The D 2 receptors would in turn allow the development of new informative signals. 147 In addition, the presence of the COMT Val allele may indirectly influence the neurodevelopment and neuroplasticity processes, ultimately leading to changes in the volume of brain areas such as the prefrontal cortex. Since COMT is responsible for DA cortical availability, 67 it may also be implicated in key neuronal processes that ultimately lead to brain morphogenesis and development. How this actually occurs remains to be established. Interestingly, a recent review has proposed that COMT influences neurodevelopment and neuro plasticity via an epistatic interaction with other genes, such as AKT1.
148 AKT1 and dopaminergic pathways have already been shown to be synergistically responsible for neuronal atrophy after chronic opiate exposure. 148, 149 Also, genetic variation in AKT1 has been linked to DA-associated prefrontal cortical structure and function in humans. 148 It is possible that the combination of different risk alleles results in impaired prefrontal activity during challenging cognitive tasks and in changes in key neurodevelopmental pathways affecting neuronal morphology and development. 150 
Limitations
The main limitation to our interpretation of the literature is that the association between a single genetic variant and an endophenotype does not necessarily imply a causal relationship between them. In other words, we hypothesized that the COMT Val 158 Met polymorphism, which affects prefrontal DA levels, may contribute to both CPT and n-back impairment and reduced prefrontal and medial temporal volume. However, schizophrenia is characterized by a complex genetic architecture, with an intricate interplay among several genes. As mentioned previously, the COMT Val 158 Met polymorphism can interact with other genes in shaping the neuro psychological profile and the brain structural alterations that characterize schizophrenia (for example, see the studies by Caldú and colleagues, 47 Zinkstok and colleagues, 80 and Dickinson and colleagues 146 ). Moreover, variables such as sex and age need to be taken into account. For example, estrogen reduces COMT enzymatic activity, and the production of estrogen varies across age. 146 Finally, the COMT Val 158 Met polymorphism interacts with environmental factors like stress. This has been suggested by a recent study reporting that individuals homozygous for Met performed significantly worse than those homozygous for Val on the n-back task under stress. 151 This highlights the importance of considering the complex interaction between genes and environment when evaluating neuro cognitive performance. 151 In view of this complexity, it is possible that the endophenotypes we found to be associated with the COMT Val 158 Met polymorphism are also related to other polymorphisms. Furthermore, there is little evidence on the association between neuropsychological tasks and brain structure in patients with schizophrenia, and the link we suggest in this review needs further investigation. With these caveats in mind, this may explain, at least in part, the biological substrate of 4 important endophenotypes that characterize schizophrenia.
Conclusion
Our review comprehensively evaluated evidence on the link between the COMT Val 158 Met polymorphism and both neuro psychological performance and brain structure in patients with schizophrenia and their relatives, and in healthy controls. The review also summarized this evidence within a biological framework that may be used to advance our knowledge on the molecular mechanisms that underlie the patho physiology of schizophrenia.
